Discover our cutting-edge preliminary program here

 

Program at the glance

Thursday, 24 March 2022
Session 1 08:00 > 10:00 What can the biology of aging offer Geroscience ?
8:00 –8:30 am
Invited contribution 1
Ana Maria Cuervo, MD, PhD, co-director of the Einstein Institute for Aging Research,Albert Einstein College of Medicine, Bronx, NY (USA)

8:30 –9:00 am
Invited contribution 2
Linda Partridge, PhD, Director of the Partridge Lab, University College London, London (UK)

9:00–9:30am
Invited contribution 3
Anne Brunet, PhD, Michele and Timothy Barakett Professor of Genetics, Stanford University, Stanford, CA

9:30–10:00am
Oral communications submitted via abstracts

Session 2 10:30 > 12:30 What can Geroscience offer to the biology of aging ?
10:00 –11:00 am
Invited contribution 1
James L. Kirkland, MD, PhD, Director of the Robert and Arlene Kogod Center onAging, Mayo Clinic, Rochester, MN (USA)

11:00 –11:30 am
Invited contribution 2
Laura Niedernhofer, MD, PhD, Professor, Universityof Minnesota, Minneapolis, MN (USA)

11:30 –12:00 pm
Invited contribution 3
Brian Kennedy, PhD, Professor, University of Singapore (Singapore)

12:00 –12:30 pm
Oral communications submitted via abstracts

Roundtable 1 13:30 > 14:30 Molecular, cellular and physiological hallmarks of aging
Invited contribution 1
Guido Kroemer, MD, PhD,Director, Kroemer lab, Sorbonne University, Paris (France)

Invited contribution 2
Luigi Ferrucci, MD, PhD, Senior Investigator, National Institute of Aging, Baltimore, MD (USA)

Invited contribution 3
Vadim Gladyshev, PhD,Director of the Gladyshev Lab, Brigham & Women's Hospital, Boston, MA (USA)

Invited contribution 4
Rafael de Cabo, PhD, Senior Investigator, National Institute of Aging, Baltimore, MD (USA)

Rondtable 2 15:00 > 15:30 Regulatory framework for geroprotectors
Invited contribution 1
Anna Lönnroth, Senior Expert, People Directorate, DG Research and Innovation, European Commission, Brussels (Belgium)

Invited contribution 2
Nir Barzilai,Director, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY (USA)

Invited contribution 3
TBC

Invited contribution 4
William K. Smith, MD,Uniformed Services University of Health Sciences, and University of South Carolina

Session 3 16:00 > 18:00 Involving new blood into geroscience
4:00 –4:30 pm
Invited contribution 1
Jamie N. Justice, PhD,Associate Professor of Gerontology and Geriatric medicine, Wake Forest School of Medicine, Winston-Salem, NC (USA)

4:30 –5:00 pm
Invited contribution 2
Benoit Lehallier, PhD, Director of Data Science, Alkahest, San Carlos, CA (USA)


5:00 –5:30 pm
Invited contribution 3
Irene Martinez de Toda,Professor,Universidad Complutense de Madrid, Madrid (Spain)

5:30 –6:00 pm
Oral communications submitted via abstracts

Friday, 25 March 2022
Session 4 08:00 > 10:00 New models in geroscience
8:00 –8:30 am
Invited contribution 1
Steven N. Austad, PhD,Chair, Department of Biology, University of Alabama, Birmingham, AL (USA)

8:30 –9:00 am
Invited contribution 2
Dario Riccardo Valenzano, PhD, Leibniz Institute on Aging, FLI, Jena, (Germany)

9:00 –9:30 am
Invited contribution 3
Alex Zhavoronkov, PhD, CEO, Insilico Medicine, Hong Kong (Hong Kong)

9:30 –10:00 am
Oral communications submitted via abstracts

Session 5 10:30 > 12:30 Geroscience and Biotechs Europe
10:30 –11:00 am
Invited contribution 1
Ann Beliën, PhD, CEO Rejuvenate Biomed, Heusden-Zolder (Belgium)

11:00 –11:30 am
Invited contribution 2
Nichola Conlon, PhD, CEO and Co-Founder, Nuchido, Nuchido, Newcastle (UK)

11:30 –12:00 pm
Invited contribution 3
Peter L.J. deKeizer, PhD,Founder and Managing Director,Cleara Biotech B.V.,Utrecht (The Netherlands)

12:00 –12:30 pm
Oral communications submitted via abstracts

Roundtable 3 13:30 > 14:30 Funding and communication
Invited contribution 1
TBC

Invited contribution 2
Stephanie Lederman,Executive Director, American Federation for Aging Research, New York, NY (USA)

Invited contribution 3
Mehmood Kahn, MD, Chief Executive Office, Life Biosciences, Boston, MA(USA)

Invited contribution 4
Viviana Perez Montes, PhD,Health Science Administrator, Division of Aging Biology, National Institute of Aging, Baltimore, MD (USA)

Roundtable 4 14:30 > 15:30 Establishing research priorities
Invited contribution 1
Felipe Sierra, PhD, Geroscience Director, Gerontopole, Toulouse University, Toulouse (France)

Invited contribution 2
Linda Fried, MD, MPH, Dean of Mailman School of Public Health, Columbia University Medical Center, New York, NY(USA)

Invited contribution 3
Matt Kaeberlein, PhD, University of Washington Medicine, Memory and Brain Wellness Center, Seattle, WA (USA)

Invited contribution 4
Ronald A. Kohanski, PhD, Director Designate of the Division of Aging Biology (DAB) at the National Institute on Aging, Baltimore, MD (USA)

Session 6 16:00 > 18:00 Designing clinical trials in geroscience
4:00 –4:30 pm
Invited contribution 1
Stephen Kritchevsky, PhD, Director of the Sticht Center for Healthy Aging and Alzheimer’s Prevention, and Wake Forest Claude D. Pepper Older Americans Independence Center, Wake Forest School of Medicine, Winston-Salem, NC (USA)

4:30 –5:00 pm
Invited contribution 2
John Newman, MD,assistant professor at the Buck Institute for Research on Aging and in the Division of Geriatrics at University of California SanFrancisco, SanFrancisco, CA (USA)

5:00 –5:30 pm
Invited contribution 3
Joan Mannick, MD, Head of Research and Development, Life Biosciences, Boston, MA (USA)

5:30 –6:00 pm
Oral communications submitted via abstracts

Copyright © key4events - All rights reserved